secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeyondSpring Inc. (BYSI)
CIK:        0001677940
Form:       8-K
Filed at:   2026-06-04T11:30:18+00:00
Accession:  0001171843-26-003908
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeyondSpring CEO Lan Huang transitions to Chairman; Min Qiu named CEO effective July 1, 2026
--------------------------------------------------------------------------------

- Dr. Lan Huang steps down as CEO effective July 1, 2026; remains Chairman; forfeits all unvested equity awards.
- Min Qiu appointed CEO; previously VP General Manager at subsidiary Wanchunbulin; mandate to execute DUBLIN-4 Phase 3 trial.
- Na Li appointed CFO; previously CFO of Wanchunbulin since Nov 2020; brings public-company financial reporting experience.
- Dr. Jiangwen Majeti appointed Vice Chair of Board; receives one-time grant of options for 100,000 ordinary shares.
- BeyondSpring focuses on Plinabulin DUBLIN-4 confirmatory trial; patent protection extends to 2036 (potentially 2041 with Hatch-Waxman).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326003908/0001171843-26-003908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326003908/f8k_060426.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer